(VIANEWS) – Freeport (FCX), Ceragon Networks Ltd. (CRNT), Paylocity Holding Corporation (PCTY) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Freeport (FCX)
25.4% sales growth and 14.38% return on equity
Freeport-McMoRan Inc. engages in the mining of mineral properties in North America, South America, and Indonesia. It primarily explores for copper, gold, molybdenum, silver, and other metals. The company's assets include the Grasberg minerals district in Indonesia; Morenci, Bagdad, Safford, Sierrita, and Miami in Arizona; Chino and Tyrone in New Mexico; and Henderson and Climax in Colorado, North America, as well as Cerro Verde in Peru and El Abra in Chile. The company was formerly known as Freeport-McMoRan Copper & Gold Inc. and changed its name to Freeport-McMoRan Inc. in July 2014. Freeport-McMoRan Inc. was incorporated in 1987 and is headquartered in Phoenix, Arizona.
Earnings Per Share
As for profitability, Freeport has a trailing twelve months EPS of $1.28.
PE Ratio
Freeport has a trailing twelve months price to earnings ratio of 38.65. Meaning, the purchaser of the share is investing $38.65 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.38%.
Yearly Top and Bottom Value
Freeport’s stock is valued at $49.47 at 16:22 EST, below its 52-week high of $54.35 and way above its 52-week low of $32.83.
Revenue Growth
Year-on-year quarterly revenue growth grew by 17.3%, now sitting on 23.79B for the twelve trailing months.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Apr 12, 2024, the estimated forward annual dividend rate is 0.6 and the estimated forward annual dividend yield is 1.11%.
2. Ceragon Networks Ltd. (CRNT)
17.6% sales growth and 4.9% return on equity
Ceragon Networks Ltd. provides wireless backhaul solutions that enable cellular operators and other wireless service providers to deliver voice and data services. Its wireless backhaul solutions use microwave and millimeter wave technology to transfer telecommunication traffic between base stations, small/distributed cells, and the core of the service provider's network. The company also offers wireless fronthaul solutions that use microwave technology for ultra-high speed, ultra-low latency communication for wireless 5G and 4G base stations. In addition, it provides IP-20 all-outdoor solutions, such as IP-20C, IP-20C-HP, IP-20S, IP-20E, and IP-20V; IP-20 split-mount/all-indoor solutions comprising IP-20N/IP-20A, IP-20F, and IP-20G; and IP-50 disaggregated solutions, including IP-50E, IP-50C, IP-50S, and IP-50FX for various short-haul, long-haul, fronthaul, and enterprise access applications. Further, the company offers network management system; and network and radio planning, site survey, solutions development, installation, network auditing and optimization, maintenance, training, and other services. It provides its services to smart-phone applications, such as internet browsing, social networking, image sharing, music, and video applications; oil and gas companies; public safety organizations; business and public institutions; broadcasters; energy utilities; and private communications networks. The company sells its products through direct sales, original equipment manufacturers, resellers, distributors, and system integrators. It operates in North America, Europe, Africa, the Asia Pacific, the Middle East, India, and Latin America. The company was formerly known as Giganet Ltd. and changed its name to Ceragon Networks Ltd. in September 2000. Ceragon Networks Ltd. was incorporated in 1996 and is headquartered in Tel Aviv, Israel.
Earnings Per Share
As for profitability, Ceragon Networks Ltd. has a trailing twelve months EPS of $0.07.
PE Ratio
Ceragon Networks Ltd. has a trailing twelve months price to earnings ratio of 38.43. Meaning, the purchaser of the share is investing $38.43 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.9%.
3. Paylocity Holding Corporation (PCTY)
12.8% sales growth and 20.9% return on equity
Paylocity Holding Corporation provides cloud-based payroll and human capital management software solutions for medium-sized organizations in the United States. The company offers Payroll and Tax Services solution to simplify payroll, automate processes and manage compliance requirements within one system; expense management, on demand payment, and garnishment solutions; human capital management and employee self-service solutions, document library, compliance dashboard, and HR edge; time and attendance solution, which tracks time and attendance data, eliminating the need for manual tracking of accruals and reducing administrative tasks; schedule tracking services; and time collection devices, including kiosks, time clocks, and mobile and web applications. In addition, the company offers talent management solutions comprising recruiting and onboarding, as well as learning, performance, and compensation management; employee benefits management and third-party administrative solutions; modern workforce solutions consisting of community, premium video, survey, and peer recognition; and analytics and insights solutions covering modern workforce index, data insights, and reporting. Further, it provides implementation and training, client, and tax and regulatory services. The company's clients include for-profit and non-profit organizations across industries, including business services, financial services, healthcare, manufacturing, restaurants, retail, technology, and others. It sells its products through sales representatives. The company was founded in 1997 and is headquartered in Schaumburg, Illinois.
Earnings Per Share
As for profitability, Paylocity Holding Corporation has a trailing twelve months EPS of $3.42.
PE Ratio
Paylocity Holding Corporation has a trailing twelve months price to earnings ratio of 50.58. Meaning, the purchaser of the share is investing $50.58 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.9%.
Volume
Today’s last reported volume for Paylocity Holding Corporation is 266797 which is 40.47% below its average volume of 448219.
Moving Average
Paylocity Holding Corporation’s worth is above its 50-day moving average of $165.40 and higher than its 200-day moving average of $171.96.
4. ExlService Holdings (EXLS)
12.7% sales growth and 22.77% return on equity
ExlService Holdings, Inc. operates as a data analytics, and digital operations and solutions company in the United States and internationally. It operates through Insurance, Healthcare, Analytics, and Emerging Business segments. The company provides digital operations and solutions and analytics-driven services across the insurance industry in areas, such as claims processing, premium and benefit administration, agency management, account reconciliation, policy research, underwriting support, new business acquisition, policy servicing, premium audit, surveys, billing and collection, commercial and residential survey, and customer service using digital technology, artificial intelligence, machine learning, and advanced automation; digital customer acquisition services using a software-as-a-service delivery model through LifePRO and LISS platforms; subrogation services; and Subrosource software platform, an end-to-end subrogation platform. It also offers CareRadius, an integrated care management offering; and health care services related to care management, utilization management, disease management, payment integrity, revenue optimization and customer engagement to healthcare payers, providers, pharmacy benefit managers, and life sciences organizations. Further, it offers predictive and prescriptive analytics in the areas of customer acquisition and lifecycle management, risk underwriting and pricing, operational effectiveness, credit and operational risk monitoring and governance, payment integrity and care management, and data management. The company was founded in 1999 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, ExlService Holdings has a trailing twelve months EPS of $1.09.
PE Ratio
ExlService Holdings has a trailing twelve months price to earnings ratio of 28.06. Meaning, the purchaser of the share is investing $28.06 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.77%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 8.3% and 10.8%, respectively.
Sales Growth
ExlService Holdings’s sales growth is 9.8% for the ongoing quarter and 12.7% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9%, now sitting on 1.67B for the twelve trailing months.
Volume
Today’s last reported volume for ExlService Holdings is 987148 which is 9.89% below its average volume of 1095600.
5. American Express (AXP)
9.1% sales growth and 32.85% return on equity
American Express Company, together with its subsidiaries, operates as integrated payments company in the United States, Europe, the Middle East and Africa, the Asia Pacific, Australia, New Zealand, Latin America, Canada, the Caribbean, and Internationally. It operates through four segments: U.S. Consumer Services, Commercial Services, International Card Services, and Global Merchant and Network Services. The company's products and services include credit card, charge card, banking, and other payment and financing products; network services; expense management products and services; and travel and lifestyle services. It also provides merchant acquisition and processing, servicing and settlement, point-of-sale marketing, and information products and services for merchants; and fraud prevention services, as well as the design and operation of customer loyalty programs. In addition, the company operates lounges at airports under Centurion Lounge brand name. It sells its products and services to consumers, small businesses, mid-sized companies, and large corporations through mobile and online applications, affiliate marketing, customer referral programs, third-party service providers and business partners, direct mail, telephone, in-house sales teams, and direct response advertising. American Express Company was founded in 1850 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, American Express has a trailing twelve months EPS of $11.22.
PE Ratio
American Express has a trailing twelve months price to earnings ratio of 19.45. Meaning, the purchaser of the share is investing $19.45 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.85%.
Previous days news about American Express(AXP)
- According to Zacks on Friday, 17 May, "These are American Express Company (AXP Quick QuoteAXP – Free Report) , Walmart Inc. (WMT Quick QuoteWMT – Free Report) , Amazon.com Inc. (AMZN Quick QuoteAMZN – Free Report) , The Goldman Sachs Group Inc. (GS Quick QuoteGS – Free Report) and Merck & Co. Inc. (MRK Quick QuoteMRK – Free Report) ."
6. Regeneron Pharmaceuticals (REGN)
5.6% sales growth and 15.28% return on equity
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.
Earnings Per Share
As for profitability, Regeneron Pharmaceuticals has a trailing twelve months EPS of $34.78.
PE Ratio
Regeneron Pharmaceuticals has a trailing twelve months price to earnings ratio of 26.01. Meaning, the purchaser of the share is investing $26.01 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.28%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 0.5%, now sitting on 13.1B for the twelve trailing months.
Sales Growth
Regeneron Pharmaceuticals’s sales growth for the next quarter is 5.6%.
Volume
Today’s last reported volume for Regeneron Pharmaceuticals is 518284 which is 9.88% above its average volume of 471642.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 3.8% and 2.6%, respectively.
7. SS&C Technologies Holdings (SSNC)
5.1% sales growth and 10.14% return on equity
SS&C Technologies Holdings, Inc., together with its subsidiaries, provides software products and software-enabled services to financial services and healthcare industries. The company owns and operates technology stack across securities accounting; front-office functions, such as trading and modeling; middle-office functions comprising portfolio management and reporting; back-office functions, such as accounting, performance measurement, reconciliation, reporting, processing and clearing, and compliance and tax reporting; and healthcare solutions consisting of claims adjudication, benefit management, care management, and business intelligence solutions. Its products and services allow professionals in the financial services and healthcare industries to automate complex business processes and are instrumental in helping its clients to manage information processing requirements. The company's software-enabled services include SS&C GlobeOp, Global Investor and Distribution Solutions, SS&C Retirement Solutions, Black Diamond Wealth Platform, CRM Solutions, Advent Managed Services, Advent Data Solutions, ALPS Advisors, and Virtual Data Rooms, as well as pharmacy, healthcare administration, and health outcomes optimization solutions. Its software products comprise portfolio/investment accounting and analytics software, portfolio management software, trading software, automation solutions, and banking and lending solutions, as well as research, analytics, risk, and training solutions. The company also provides professional services that includes consulting and implementation services consisting of initial system installation, conversion of historical data, and ongoing training and support, as well as product support services. It operates in the United States; Europe, the Middle East, and Africa; the Asia Pacific and Japan; Canada; and the Americas. The company was founded in 1986 and is headquartered in Windsor, Connecticut.
Earnings Per Share
As for profitability, SS&C Technologies Holdings has a trailing twelve months EPS of $2.39.
PE Ratio
SS&C Technologies Holdings has a trailing twelve months price to earnings ratio of 25.95. Meaning, the purchaser of the share is investing $25.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.14%.
